000			01564 a2200409 4500
005			20250515091325.0
264		0	_c20080118
008			200801s 0 0 eng d
022			_a1521-0103
024	7		_a10.1124/jpet.107.128207 _2doi
040			_aNLM _beng _cNLM
100	1		_aMuehlmann, Amber M
245	0	0	_aPemoline (2-amino-5-phenyl-1,3-oxazol-4-one)-induced self-injurious behavior: a rodent model of pharmacotherapeutic efficacy. _h[electronic resource]
260			_bThe Journal of pharmacology and experimental therapeutics _cJan 2008
300			_a214-23 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntipsychotic Agents _xtherapeutic use
650	0	4	_aCentral Nervous System Stimulants
650	0	4	_aDisease Models, Animal
650	0	4	_aFructose _xanalogs & derivatives
650	0	4	_aGrooming _xdrug effects
650	0	4	_aMale
650	0	4	_aMotor Activity _xdrug effects
650	0	4	_aPemoline
650	0	4	_aRats
650	0	4	_aRats, Long-Evans
650	0	4	_aRisperidone _xtherapeutic use
650	0	4	_aSelf-Injurious Behavior _xchemically induced
650	0	4	_aTopiramate
650	0	4	_aTreatment Outcome
650	0	4	_aValproic Acid _xtherapeutic use
700	1		_aBrown, Brandon D
700	1		_aDevine, Darragh P
773	0		_tThe Journal of pharmacology and experimental therapeutics _gvol. 324 _gno. 1 _gp. 214-23
856	4	0	_uhttps://doi.org/10.1124/jpet.107.128207 _zAvailable from publisher's website
999			_c17446539 _d17446539